Fair point. Just to be clear though, I don’t say “right” in support of tarriffs, I say, right in terms of not accidentally multiplying the damage by 4x the original plan.
Although, now you got me thinking maybe the 4x worse damage wasn’t even an accident.
Over the last year their stock has been going down, but last week, it was up a little compared to companies like Moderna and Pfizer. Not by much, but it seemed weird the company actually announced a buy back of their own stock.
It would be interesting to know if the majority of shares were bought back before or after the giant crash. If it was before the crash, that would mean the company would be kind of fucked over by their own buy back. If the majority of shares were bought after the crash, that would be an odd choice but I guess if they mysteriously make a recovery it would be a win.
They couldn’t hire someone to do the tariff math ‘right’ because there is no ‘right’ math to do.
Fair point. Just to be clear though, I don’t say “right” in support of tarriffs, I say, right in terms of not accidentally multiplying the damage by 4x the original plan.
Although, now you got me thinking maybe the 4x worse damage wasn’t even an accident.
There’s a bioscience company with some really shady gov ties that was one of the only vaccine manufacturers that didn’t completely tank in the stock market last week when FDA cuts were announced.
Over the last year their stock has been going down, but last week, it was up a little compared to companies like Moderna and Pfizer. Not by much, but it seemed weird the company actually announced a buy back of their own stock.
It would be interesting to know if the majority of shares were bought back before or after the giant crash. If it was before the crash, that would mean the company would be kind of fucked over by their own buy back. If the majority of shares were bought after the crash, that would be an odd choice but I guess if they mysteriously make a recovery it would be a win.